A detailed history of J. Goldman & CO LP transactions in Pfizer Inc stock. As of the latest transaction made, J. Goldman & CO LP holds 697,500 shares of PFE stock, worth $19.2 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
697,500
Holding current value
$19.2 Million
% of portfolio
0.6%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.87 Million - $2.19 Million
58,429 New
58,429 $1.94 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $5.89 Million - $7.3 Million
-128,713 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $5.32 Million - $7.88 Million
128,713 New
128,713 $7.6 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $1.07 Million - $1.35 Million
-31,834 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $1.01 Million - $1.19 Million
31,834 New
31,834 $1.17 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.